The suppressive effects of SOCE inhibition on cytokine expression in T cells of IBD patients are consistent with a report of decreased production of IFNγ, IL‐2, and IL‐17A by LPMCs of IBD patients that had been stimulated ex vivo in the presence of the SOCE inhibitor Synta 66 (Di Sabatino et al, 2009). The gene discussed is IL17A; the disease is inflammatory bowel disease.